Clover Health CLOV 深 沪
等待开盘 05-18 09:30:00 美东时间
3.47
-0.020
-0.57%
华盛通- 最 高3.50
- 今 开3.44
- 成交量 1067.20万股
- 最 低 3.36
- 昨 收 3.49
- 总市值 18.28亿
- 52周最高 3.92
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.58
- 委 比 -20.12%
- 总股本 5.27亿
- 历史最高 28.85
- 量 比 1.01
- 振 幅 4.01%
- 历史最低 0.606
- 每 手 1
- 风险率 0.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Clover Health 2026财年Q1营收7.49亿美元，同比增长62.1%；归母净利润0.27亿美元，扭亏为盈
华盛资讯5月7日讯，Clover Health公布2026财年Q1业绩，公司Q1营收7.49亿美元，同比增长62.1%，归母净利润0.27亿美元，扭亏为盈。
05-07 08:34
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Fiserv Q1 2026 Earnings Call: Complete Transcript
On Tuesday, Fiserv (NASDAQ:FISV) discussed first-quarter financial results duri...
05-05 21:20
UnitedHealth lifts managed care peers after Q1 beat, guidance raise
Shares of managed care organizations rose in the premarket on Tuesday after UnitedHealth (UNH), the industry bellwether for the earnings season, reported better-than-expected Q1 2026 results and incre...
04-21 18:15
Managed care rebounds after Medicare rate decision
Managed care stocks bounced back from a year-to-date decline to reach a three-month high on Tuesday after the Centers for Medicare & Medicaid Services (CMS) finalized a better-than-expected reimbursem...
04-08 01:39
Clover Health Investments CFO Peter Kuipers Steps Down, Effective March 30; Clay Thornton Appointed Interim Successor
Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that Peter Kuipers is
04-01 20:35
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
Clover Health announced Peter Kuipers' departure as CFO, effective March 30, 2026, with Clay Thornton appointed as interim CFO. Kuipers will remain in an advisory role until April 24 to ensure a smooth transition. The company reaffirmed its financial guidance for 2026. Kuipers expressed pride in Clover's achievements and confidence in its future, while CEO Andrew Toy praised Kuipers' contributions and welcomed Thornton's leadership. Thornton brin...
04-01 12:30
美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Clover Health's Subsidiary Publishes Whitepaper on "Driving Clinical Excellence in Chronic Disease" Highlighting Use of Counterpart Assistant Associated With 18%–22% Fewer Flu-Related Acute Care Events Among COPD And CHF Patients
Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), and a leading AI-powered physician-enablement platform
03-19 20:36
Clover Health study links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients
Clover Health study links Counterpart Assistant use to 22% fewer flu-related acute care encounters in COPD patients Counterpart Health, a Clover subsidiary, released a whitepaper analyzing how use of Counterpart Assistant flu-related clinical insights affected vaccination rates and flu-related acute
03-19 20:35
